SNWV:OTC-SANUWAVE Health Inc (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 22.84

Change

+0.44 (+1.96)%

Market Cap

USD 20.67B

Volume

4.73K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SEMHF Siemens Healthineers AG

-2.13 (-3.85%)

USD 61.66B
SMMNY Siemens Healthineers AG ADR

-0.49 (-1.82%)

USD 61.36B
RYLPF Koninklijke Philips N.V

-0.10 (-0.39%)

USD 23.84B
SONVF Sonova Holding AG

-0.50 (-0.14%)

USD 22.14B
SNNUF Smith & Nephew plc

N/A

USD 12.50B
WILLF Demant A/S

N/A

USD 8.39B
GNGBF Getinge AB

N/A

USD 5.12B
AMBBY Ambu A/S

N/A

USD 5.04B
AMBFF Ambu A/S

N/A

USD 5.04B
GGNDF GN Store Nord A/S

-3.21 (-15.10%)

USD 3.10B

ETFs Containing SNWV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A 97% N/A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A 97% N/A 99% N/A
Trailing 12 Months  
Capital Gain N/A 97% N/A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A 97% N/A 99% N/A
Trailing 5 Years  
Capital Gain 13,335.29% 97% N/A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 13,335.29% 97% N/A 99% N/A
Average Annual (5 Year Horizon)  
Capital Gain 638.35% 92% A 94% A
Dividend Return 638.35% 92% A 93% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9,136.36% 7% C- 4% F
Risk Adjusted Return 6.99% 50% F 40% F
Market Capitalization 20.67B 96% N/A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector